Mycophenolic Acid Tablet, Delayed Release
Product Images NDC 70377-040

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mycophenolic Acid (NDC 70377-040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocon Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label 180 mg (Mycophenolic Acid 180mg 120)

Mycophenolic Acid Delayed-Release Tablets USP, 180 mg strength, oral tablet in a 120-count package. Label includes storage instructions and pharmacist dispensing notes. Manufactured by Biocon Pharma Limited, Bengaluru, India, and labeled for Biocon Pharma Inc., USA. NDC 70377-039-11 is displayed on the label.*

FDA Label Image

Package Label 360 mg (Mycophenolic Acid 360mg 120)

Label for Mycophenolic Acid Delayed-Release Tablets USP 360 mg by Biocon Pharma Inc., featuring the NDC 70377-040-11. The label states the package contains 120 tablets for oral use, highlights dosage and storage conditions, and includes manufacturer details.*

FDA Label Image

Chemical Structure (Mycophenolic Acid Structure)

Chemical structure of Mycophenolic Acid showing its molecular arrangement including various functional groups and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.